scholarly article | Q13442814 |
P50 | author | Kenneth A. Jacobson | Q37387267 |
Adriaan P IJzerman | Q40222626 | ||
P2093 | author name string | J Kim | |
Q Jiang | |||
J K Von Frijtag Drabbe Künzel | |||
P2860 | cites work | The probable arrangement of the helices in G protein-coupled receptors. | Q40872681 |
Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic r | Q41428196 | ||
D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture | Q42507079 | ||
Receptor binding profiles of amiloride analogues provide no evidence for a link between receptors and the Na+/H+ exchanger, but indicate a common structure on receptor proteins | Q43600354 | ||
Projection structure of rhodopsin | Q59098567 | ||
Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor | Q63916823 | ||
Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes | Q72827364 | ||
Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor | Q24612312 | ||
Molecular characterization of a human brain adenosine A2 receptor | Q28212728 | ||
Iodine-125-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors | Q30462475 | ||
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential | Q36332205 | ||
P433 | issue | 2-3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 269-272 | |
P577 | publication date | 1996-08-01 | |
P1433 | published in | European Journal of Pharmacology | Q1376712 |
P1476 | title | Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition | |
P478 | volume | 310 |
Q44247309 | 2- and 8-alkynyladenosines: conformational studies and docking to human adenosine A3 receptor can explain their different biological behavior |
Q40452318 | A "locked-on," constitutively active mutant of the adenosine A1 receptor. |
Q39424469 | A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor. |
Q28283019 | A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists |
Q91406530 | A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states |
Q35602688 | Adenosine receptor agonists: from basic medicinal chemistry to clinical development |
Q37724968 | Adenosine receptor modeling: what does the A2A crystal structure tell us? |
Q63916757 | Allosteric modulation of A2A adenosine receptors by amiloride analogues and sodium ions |
Q36172721 | Allosteric modulation of the adenosine family of receptors |
Q37724971 | Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands. |
Q30376612 | Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure. |
Q43276048 | Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor |
Q42536494 | Identification of the adenine binding site of the human A1 adenosine receptor |
Q44636374 | Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists |
Q61785701 | Molecular Dynamics Simulations Reveal Insights into Key Structural Elements of Adenosine Receptors |
Q92135187 | Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends |
Q46581709 | Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies |
Q36816987 | Molecular modeling of adenosine receptors: new results and trends. |
Q36253713 | Mutagenesis Reveals Structure−Activity Parallels between Human A2AAdenosine Receptors and Biogenic Amine G Protein-Coupled Receptors |
Q28364092 | Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides |
Q90916644 | Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia |
Q44784457 | Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site |
Q51034650 | Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study |
Q33292715 | Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we? |
Q31421740 | Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation |
Q47333337 | Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms |
Q37769342 | Structural features of adenosine receptors: from crystal to function. |
Q38686607 | The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges. |
Q37876534 | The structure of the adenosine receptors: implications for drug discovery. |
Q43510634 | Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine. |
Search more.